Cited by 429Inflammatory Bowel DiseaseOcular Diseases and Behçet’s SyndromeColorectal Cancer Screening and Detection

The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.

East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort

Open access

Burisch, J, Pedersen, N, Čuković-Čavka, S, Brinar, M, Kaimakliotis, I, Duricova, D, Shonová, O, Vind, I, Avnstrøm, S, Thorsgaard, N, Andersen, V, Krabbe, S, Dahlerup, J F, Salupere, R, Nielsen, K R, Olsen, J, Manninen, P, Collin, P, Tsianos, E V, Katsanos, K H, Ladefoged, K, Lakatos, L, Björnsson, E, Ragnarsson, G, Bailey, Y, Odes, S, Schwartz, D, Martinato, M, Lupinacci, G, Milla, M, De Padova, A, D'Incà, R, Beltrami, M, Kupcinskas, L, Kiudelis, G, Turcan, S, Tighineanu, O, Mihu, I, Magro, F, Barros, L F, Goldis, A, Lazar, D, Belousova, E, Nikulina, I, Hernandez, V, Martinez-Ares, D, Almer, S, Zhulina, Y, Halfvarson, J, Arebi, N, Sebastian, S, Lakatos, P L, Langholz, E, Munkholm, P, for the EpiCom-group·2014·Gut

DOI 10.1136/gutjnl-2013-304636

Open this paper in CoChat — free account

Abstract

Objective: The incidence of inflammatory bowel disease (IBD) is increasing in Eastern Europe. The reasons for these changes remain unknown. The aim of this study was to investigate whether an East–West gradient in the incidence of IBD in Europe exists. Design: A prospective, uniformly diagnosed, population based inception cohort of IBD patients in 31 centres from 14 Western and eight Eastern European countries covering a total background population of approximately 10.1 million people was created. One-third of the centres had previous experience with inception cohorts. Patients were entered into a low cost, web based epidemiological database, making participation possible regardless of socioeconomic status and prior experience. Results: 1515 patients aged 15 years or older were included, of whom 535 (35%) were diagnosed with Crohn's disease (CD), 813 (54%) with ulcerative colitis (UC) and 167 (11%) with IBD unclassified (IBDU). The overall incidence rate ratios in all Western European centres were 1.9 (95% CI 1.5 to 2.4) for CD and 2.1 (95% CI 1.8 to 2.6) for UC compared with Eastern European centres. The median crude annual incidence rates per 100 000 in 2010 for CD were 6.5 (range 0–10.7) in Western European centres and 3.1 (range 0.4–11.5) in Eastern European centres, for UC 10.8 (range 2.9–31.5) and 4.1 (range 2.4–10.3), respectively, and for IBDU 1.9 (range 0–39.4) and 0 (range 0–1.2), respectively. In Western Europe, 92% of CD, 78% of UC and 74% of IBDU patients had a colonoscopy performed as the diagnostic procedure compared with 90%, 100% and 96%, respectively, in Eastern Europe. 8% of CD and 1% of UC patients in both regions underwent surgery within the first 3 months of the onset of disease. 7% of CD patients and 3% of UC patients from Western Europe received biological treatment as rescue therapy. Of all European CD patients, 20% received only 5-aminosalicylates as induction therapy. Conclusions: An East–West gradient in IBD incidence exists in Europe. Among this inception cohort—including indolent and aggressive cases—international guidelines for diagnosis and initial treatment are not being followed uniformly by physicians.

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2013-304636

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.001 · Cited by 4,833
Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J., Gasché, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,410
Ulcerative Colitis
Ford Alexander, C., Paul, M., Hanauer Steven, B., 谭蓓, & Dong, W. Z. (2001) · Cited by 3,021
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
Kornbluth, A. A., & Sachar, D. B. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,032
AGE STANDARDIZATION OF RATES: A NEW WHO STANDARD
Ahmad, O. B., Boschi-Pinto, C., López, A. D., Murray, C. J. L., Lozano, R., & Inoue, M. (2000) · Cited by 1,793
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Dignass, A., Lindsay, J. O., Sturm, A., Windsor, A., Colombel, J.-F., Allez, M., D'Haens, G., D'Hoore, A., Mantzaris, G., Novacek, G., et al. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.002 · Cited by 1,548
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
Dignass, A. U., Assche, G. V., Lindsay, J. O., Lémann, M., Söderholm, J. D., Colombel, J., Danese, S., D’Hoore, A., Gassull, M. À., Gomollón, F., et al. (2010) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2009.12.002 · Cited by 1,508
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
Assche, G. V., Dignass, A. U., Panés, J., Beaugerie, L., Karagiannis, J. A., Allez, M., Ochsenkühn, T., Orchard, T., Rogler, G., Louis, E. J., et al. (2010) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2009.12.003 · Cited by 1,444
Guidelines for the management of inflammatory bowel disease in adults
Mowat, C., Cole, A., Windsor, A. C. J., Ahmad, T., Arnott, I. D., Driscoll, R., Mitton, S. G., Orchard, T. R., Rutter, M. D., Younge, L., et al. (2011) · Gut · doi:10.1136/gut.2010.224154 · Cited by 1,433
Management of Crohn's Disease in Adults
Lichtenstein, G. R., Hanauer, S. B., & Sandborn, W. J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.168 · Cited by 1,184

Show all 46 references

Sorted by citations

Items 101–200 of 427

Clinical guidelines. Crohn’s disease (К50), adults
Shelygin, Y. A., Ivashkin, V. T., Иванович, А. С., Reshetov, I. V., Maev, I. V., Александровна, Б. Е., Vardanyan, A. V., Александровна, Н. Б., Adamyan, L. V., Drapkina, O. M., et al. (2023) · Koloproktologia · doi:10.33878/2073-7556-2023-22-3-10-49 · Cited by 54
Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Inception Cohort
Burisch, J. M., Vardi, H., Pedersen, N. K., Brinar, M., Cukovic-Cavka, S., Kaimakliotis, I. P., Ďuricová, D., Bortlík, M., Shonová, O., Vind, I., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000250 · Cited by 54
“3 million from Eastern Europe) and included a total number of incident 1560 adult and pediatric-onset IBD patients.(10) Patients were diagnosed with CD, UC, or IBDU according to the Copenhagen Diagnostic Criteria.”
MethodSelf-citation
Epidemiology of inflammatory bowel disease. State of the problem (review)
Knyazev, O. V., Шкурко, Т. В., Валерьевна, К. А., Veselov, А. V., & Никонов, Е. Л. (2020) · Russian Journal of Evidence-Based Gastroenterology · doi:10.17116/dokgastro2020902166 · Cited by 54
Incidence and Paris Classification of Pediatric Inflammatory Bowel Disease
Müller, K. E., Lakatos, P. L., Papp, M., & Veres, G. (2014) · Gastroenterology Research and Practice · doi:10.1155/2014/904307 · Cited by 53
“It is of interest that the incidences correlated with the GDP of each country [24].”
BackgroundSelf-citation
Epidemiology of inflammatory bowel disease in racial and ethnic migrant groups
Misra, R., Faiz, O. D., Munkholm, P. S., Burisch, J. M., & Arebi, N. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i3.424 · Cited by 53
Self-citation
Brusatol ameliorates 2, 4, 6-trinitrobenzenesulfonic acid-induced experimental colitis in rats: Involvement of NF-κB pathway and NLRP3 inflammasome
Zhou, J., Wang, T., Dou, Y., Huang, Y., Qu, C. F., Jiansheng, G., Huang, Z., Xie, Y., Huang, P., Lin, Z., et al. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.09.008 · Cited by 52
Therapeutic and Immunologic Effects of Short-Chain Fatty Acids in Inflammatory Bowel Disease: A Systematic Review
Ventura, I., Chomon-García, M., Tomás‐Aguirre, F., Palau-Ferrè, A. M., Legidos‐Garcia, M. E., Murillo-Llorente, M. T., & Pérez-Bermejo, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010879 · Cited by 53
Inflammatory bowel disease course in Crohn’s disease: Is the natural history changing?
Golovics, P. A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i12.3198 · Cited by 51
Inflammatory bowel disease epidemiology in São Paulo State, Brazil
Galhardi Gasparini, R., Sassaki, L. Y., & Saad-Hossne, R. (2018) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s176583 · Cited by 50
“19,20 There is little information on IBD epidemiology in Latin America, with data from countries such as Argentina, Uruguay, Puerto Rico, and Mexico referring to the beginning of the 21st century in particular.”
Moxibustion combined with acupuncture increases tight junction protein expression in Crohn’s disease patients
Shang, H.-X. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i16.4986 · Cited by 48
The Natural History of IBD: Lessons Learned
Weimers, P., & Munkholm, P. (2018) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-018-0173-3 · Cited by 49
Self-citation
Maximizing the diagnostic information from biopsies in chronic inflammatory bowel diseases: recommendations from the Erlangen International Consensus Conference on Inflammatory Bowel Diseases and presentation of the IBD-DCA score as a proposal for a new index for histologic activity assessment in ulcerative colitis and Crohn’s disease
Lang‐Schwarz, C., Agaimy, A., Atreya, R. N., Becker, C., Danese, S., Fléjou, J., Gaßler, N., Grabsch, H. I., Hartmann, A., Kamarádová, K., et al. (2020) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-020-02982-7 · Cited by 47
Accuracy and cost of diagnostic strategies for patients with suspected Crohn's disease
Maconi, G., Bolzoni, E., Giussani, A., Friedman, A. B., & Duca, P. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.08.005 · Cited by 46
Dyospiros kaki phenolics inhibit colitis and colon cancer cell proliferation, but not gelatinase activities
Direito, R., Lima, A., Rocha, J. P., Ferreira, R. B., Mota, J., Rebelo, P., Fernandes, A. M. A., Pinto, R. M. A., Alves, P. M., Bronze, R., et al. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.03.002 · Cited by 45
“Worldwide incidence and prevalence of inflammatory bowel diseases (IBD) have been dramatically increasing over time, evidencing its emergence as a global disease [1,2].”
Background
Systematic review with meta‐analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease
Tepler, A., Narula, N., Peek, R. M., Patel, A. A., Edelson, C. V., Colombel, J., & Shah, S. C. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15306 · Cited by 45
Gastrointestinal diseases and their oro-dental manifestations: Part 2: Ulcerative colitis
Tan, C. X. W., Brand, H. S., de Boer, N. K. H., & Forouzanfar, T. (2017) · BDJ · doi:10.1038/sj.bdj.2017.37 · Cited by 44
Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database
Kürti, Z., Végh, Z., Golovics, P. A., Fadgyas‐Freyler, P., Gecse, K. B., Gönczi, L., Gimesi-Országh, J., Lovasz, B. D., & Lakatos, P. L. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.07.012 · Cited by 43
“The use of biological therapy was lower compared to rates reported in the Western European countries [7,8].”
BackgroundMethodResultInfluentialSelf-citation
Is gallstone disease associated with inflammatory bowel diseases? A meta‐analysis
Zhang, F. M., Xu, C., Shan, G., Chen, H. T., & Xu, G. Q. (2015) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12286 · Cited by 43
Epidemiological trends of pediatric IBD in Italy: A 10-year analysis of the Italian society of pediatric gastroenterology, hepatology and nutrition registry
Alvisi, P., Labriola, F., Scarallo, L., Gandullia, P., Knafelz, D., Bramuzzo, M., Zuin, G., Pastore, M. N., Illiceto, M. T., Miele, E., et al. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.12.018 · Cited by 43
Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort
Végh, Z., Burisch, J. M., Pedersen, N., Kaimakliotis, I. P., Ďuricová, D., Bortlík, M., Vinding, K. K., Avnstrøm, S., Olsen, J., Nielsen, K. R., et al. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv099 · Cited by 42
Self-citation
Current stage in inflammatory bowel disease: What is next?
Gómez, G. J. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i40.11282 · Cited by 40
Management of the Psychological Impact of Inflammatory Bowel Disease
Marín‐Jiménez, I., Montoya, M. G., Panadero, A., Cañas, M., Modino, Y., de Santos, C. R., Guardiola, J., Carmona, L., & Acosta, M. B. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001205 · Cited by 41
Has the Incidence of Inflammatory Bowel Disease Peaked? Evidence From the Population-Based NorDIBD Cohort 1978–2020
Larsen, L., Sandri, A. K., Fallingborg, J., Jacobsen, B. A., Jacobsen, H., Bøgsted, M., Drewes, A. M., & Jess, T. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002187 · Cited by 40
“1/100,000 person-years in 2010 for the age group younger than 15 years (25).”
Background
Promoter methylation of the MGAT3 and BACH2 genes correlates with the composition of the immunoglobulin G glycome in inflammatory bowel disease
Klasić, M., Markulin, D., Vojta, A., Samaržija, I., Biruš, I., Dobrinić, P., Ventham, N. T., Trbojević‐Akmačić, I., Šimurina, M., Štambuk, J., et al. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0507-y · Cited by 41
“Florence cohort was collected through the network of the Italian Group for IBD (IG-IBD) since the beginning of 2001 and first described in 2005 [1] following an internal validation of phenotyping.”
MethodSelf-citation
Immunochip Meta-Analysis of Inflammatory Bowel Disease Identifies Three Novel Loci and Four Novel Associations in Previously Reported Loci
Hong, M., Ye, B. D., Yang, S., Jung, S., Lee, H., Kim, B. M., Lee, S. B., Hong, J., Baek, J., Park, S. H., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy002 · Cited by 40
Disease course of inflammatory bowel disease unclassified in a European population‐based inception cohort: An Epi‐IBD study
Burisch, J. M., Zammit, S. C., Ellul, P., Turcan, S., Ďuricová, D., Bortlík, M., Andersen, K. W., Andersen, V. C., Kaimakliotis, I. P., Fuméry, M., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14563 · Cited by 39
Self-citation
Ethnic differences in inflammatory bowel disease: Results from the United Kingdom inception epidemiology study
Misra, R., Limdi, J. K., Cooney, R. M., Sakuma, S., Brookes, M., Fogden, E. N., Pattni, S. S., Sharma, N., Iqbal, T. H., Munkholm, P., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i40.6145 · Cited by 39
Self-citation
Tailored Hydrogels as Delivery Platforms for Conditioned Medium from Mesenchymal Stem Cells in a Model of Acute Colitis in Mice
Sendón-Lago, J., Rio, L. G., Eiró, N., Díaz‐Rodríguez, P., Ávila, L., Gonzalez, L. O., Vizoso, F. J., Pérez-Fernández, R., & Landín, M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081127 · Cited by 38
“In addition, the incidence and prevalence of IBD have increased dramatically over the last few decades, growing as a public health concern since they can lead to lifethreatening problems [2,3].”
Background
The value of serum antibodies in differentiating inflammatory bowel disease, predicting disease activity and disease course in the newly diagnosed patient
Smids, C., Horje, C. S. H. T., Groenen, M. J. M., van Koolwijk, E., Wahab, P. J., & van Lochem, E. G. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1344875 · Cited by 38
“colon, which may influence clinical decision making [3,4].”
Background
Viewpoint: Inflammatory Bowel Diseases Among Immigrants From Low- to High-Incidence Countries: Opportunities and Considerations
Agrawal, M., Burisch, J. M., Colombel, J., & Shah, S. C. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz139 · Cited by 39
Self-citation
Tools for primary care management of inflammatory bowel disease: Do they exist?
Bennett, A. L., Munkholm, P. S., & Andrews, J. M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i15.4457 · Cited by 39
Self-citation
Decreased Expression of Cystathionine β-Synthase Exacerbates Intestinal Barrier Injury in Ulcerative Colitis
Chen, S., Zuo, S., Zhu, J., Yue, T., Bu, D., Wang, X., Wang, P., Pan, Y., & Liu, Y. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz027 · Cited by 37
Risk Factors Associated with Impaired Ovarian Reserve in Young Women of Reproductive Age with Crohn’s Disease
Zhao, Y., Chen, B., He, Y., Zhang, S., Qiu, Y., Feng, R., Yang, H., Zeng, Z., Ben‐Horin, S., Chen, M., et al. (2020) · Intestinal Research · doi:10.5217/ir.2019.00103 · Cited by 37
Cost Burden of Crohn’s Disease and Ulcerative Colitis in the 10-Year Period Before Diagnosis—A Danish Register-Based Study From 2003–2015
Vadstrup, K., Alulis, S., Borsi, A., Gustafsson, N., Nielsen, A. H., Wennerström, C., Jørgensen, T. R., Qvist, N., & Munkholm, P. S. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz265 · Cited by 36
Self-citation
Incidence rates and disease course of paediatric inflammatory bowel diseases in Western Hungary between 1977 and 2011
Lovasz, B. D., Lakatos, L., Horváth, Á., Pandúr, T., Erdélyi, Z., Balogh, M., Szipócs, I., Végh, Z., Veres, G., Müller, K. E., et al. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.12.013 · Cited by 35
Self-citation
Quality improvement project identifies factors associated with delay in IBD diagnosis
Walker, G., Lin, S., Chanchlani, N., Thomas, A., Hendy, P. J., Heerasing, N. M., Moore, L., Green, H., Chee, D., Bewshea, C., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15885 · Cited by 35
Prevalence and patient awareness of inflammatory bowel disease in Kazakhstan: a cross-sectional study
Kaibullayeva, J. A., Ualiyeva, A. Y., Oshibayeva, A., Dushpanova, A., & Marshall, J. K. (2020) · Intestinal Research · doi:10.5217/ir.2019.00099 · Cited by 35
Dietary risk factors for inflammatory bowel diseases in a high‐risk population: Results from the Faroese IBD study
Hammer, T., Lophaven, S. N., Nielsen, K. R., Petersen, M. S., Munkholm, P., Weihe, P., Burisch, J., & Lynge, E. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619852244 · Cited by 34
Self-citation
Epithelial NAD+ depletion drives mitochondrial dysfunction and contributes to intestinal inflammation
Novak, E. A., Crawford, E. C., Mentrup, H. L., Griffith, B. D., Fletcher, D. M., Flanagan, M. R., Schneider, C., Firek, B., Rogers, M. B., Morowitz, M. J., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1231700 · Cited by 34
Perception of disease burden and treatment satisfaction in patients with ulcerative colitis from outpatient clinics in Spain: UC-LIFE survey
Carpio, D., López–Sanromán, A., Calvet, X., Romero, C., Cea‐Calvo, L., Juliá, B., & Argüelles‐Arias, F. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000658 · Cited by 34
Inflammatory bowel diseases in Faroese‐born Danish residents and their offspring: further evidence of the dominant role of environmental factors in IBD development
Hammer, T., Lophaven, S., Nielsen, K. R., von Euler‐Chelpin, M., Weihe, P., Munkholm, P. S., Burisch, J. M., & Lynge, E. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13975 · Cited by 34
“Furthermore, for CD patients’ disease was primarily located in the colon (L2)(7) and the average age at onset is higher in the Faroe Islands than in the rest of Europe.(10)”
BackgroundInfluentialSelf-citation
Development of a Novel Predictive Model for the Clinical Course of Crohnʼs Disease
Park, Y., Cheon, J. H., Park, Y. L., Ye, B. D., Kim, Y. S., Han, D. S., Kim, J. S., Hong, S. N., Kim, Y. H., Jeon, S. R., et al. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001106 · Cited by 35
Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort—An ECCO-EpiCom Study
Burisch, J. M., Végh, Z., Katsanos, K. H., Christodoulou, D. K., Lazăr, D. C., Goldis, A., O'Morain, C. A., Fernández, A., Pereira, S., Myers, S., et al. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx077 · Cited by 32
Self-citation
Prevalence, incidence and mortality of inflammatory bowel disease in Catalonia. A population-based analysis
Brunet, E., Roig, C., Vela, E., Clèries, M., Melcarne, L., Villòria, A., Pontes, C., & Calvet, X. (2018) · Annals of Medicine · doi:10.1080/07853890.2018.1523550 · Cited by 32
Diagnostic delay in patients with inflammatory bowel disease in Austria
Austrian IBD Study Group (ATISG), Novacek, G., Gröchenig, H. P., Haas, T., Wenzl, H., Steiner, P., Koch, R., Feichtenschlager, T., Eckhardt, G., Mayer, A., et al. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-1451-3 · Cited by 32
The clinical course of Crohn’s disease in a Danish population‐based inception cohort with more than 50 years of follow‐up, 1962‐2017
Burisch, J. M., Lophaven, S., Langholz, E., & Munkholm, P. S. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16615 · Cited by 32
Self-citation
Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCREST-CD)
Matsuoka, K., Fujii, T., Okamoto, R., Yamada, A., Kunisaki, R., Matsuura, M., Watanabe, K., Shiga, H., Takatsu, N., Bamba, S., et al. (2022) · Journal of Gastroenterology · doi:10.1007/s00535-022-01907-2 · Cited by 32
“In general, CD is characterized by chronic inflammation that may occur in any segment of the gastrointestinal tract, but mostly in the ileocecal region [1, 3, 5].”
Background
Temporal Change in Phenotypic Behaviour in Patients with Crohn’s Disease: Do Indian Patients Behave Differently from Western and Other Asian Patients?
Kalaria, R., Desai, D., Abraham, P., Joshi, A. G., Gupta, T., & Shah, S. R. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv202 · Cited by 30
“2] 21 [20] Cohort with 10 years’ data [n = 38] [p = 0.”
Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study
Zammit, S. C., Ellul, P., Girardin, G., Valpiani, D., Nielsen, K. R., Olsen, J., Goldis, A., Lazăr, D. C., Shonová, O., Novàkovâ, M., et al. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001238 · Cited by 31
Self-citation
Incidence and prevalence of inflammatory bowel disease in Devon, UK
Hamilton, B., Green, H., Heerasing, N. M., Hendy, P. J., Moore, L., Chanchlani, N., Walker, G., Bewshea, C., Kennedy, N. A., Ahmad, T., et al. (2020) · Frontline Gastroenterology · doi:10.1136/flgastro-2019-101369 · Cited by 32
RETRACTED ARTICLE: Protective effect of sarsasapogenin in TNBS induced ulcerative colitis in rats associated with downregulation of pro-inflammatory mediators and oxidative stress
Mandlik, D. S., Mandlik, S. K., & Patel, S. S. (2021) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2021.1955919 · Cited by 31
Retracted
Clinical and Demographic Features and Treatment Approaches for Inflammatory Bowel Diseases (Crohn’s Disease, Ulcerative Colitis) in the Russia. The Primery Results of the Analysis of the National Register
Александровна, Б. Е., Shelygin, Y. A., Иванович, А. С., Хатьков, И. Е., Бакулин, И. Г., Skalinskaya, M. I., Knyazev, O. V., Валерьевна, К. А., Шкурко, Т. В., Александровна, Н. Б., et al. (2023) · Koloproktologia · doi:10.33878/2073-7556-2023-22-1-65-82 · Cited by 30
The role of smoking and alcohol behaviour in the management of inflammatory bowel disease
Khasawneh, M., Spence, A. D., Addley, J., & Allen, P. B. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.10.004 · Cited by 30
Quality of care in inflammatory bowel diseases: What is the best way to better outcomes?
Strohl, M., Gönczi, L., Kurt, Z., Bessissow, T., & Lakatos, P. L. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i22.2363 · Cited by 31
Self-citation
The use of 5‐aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow‐up – an Epi‐IBD study
Burisch, J. M., Bergemalm, D., Halfvarson, J., Domislović, V., Krznarić, Ž., Goldis, A., Dahlerup, J. F., Oksanen, P., Collin, P., de Castro, L., et al. (2020) · United European Gastroenterology Journal · doi:10.1177/2050640620945949 · Cited by 30
Self-citation
Comprehensive investigations of fibroin and poly(ethylenimine) functionalized fibroin nanoparticles for ulcerative colitis treatment
Phạm, D. T., Tetyczka, C., Hartl, S., Absenger‐Novak, M., Fröhlich, E., Tiyaboonchai, W., & Roblegg, E. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101484 · Cited by 30
Therapeutic potential of tonsil-derived mesenchymal stem cells in dextran sulfate sodium-induced experimental murine colitis
Yu, Y., Song, E. M., Lee, K. E., Joo, Y.-H., Kim, S., Moon, C. M., Kim, H. Y., Jung, S.-A., & Jo, I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183141 · Cited by 29
Temporal trends in non-stricturing and non-penetrating behaviour at diagnosis of Crohn's disease in Örebro, Sweden: A population-based retrospective study
Zhulina, Y., Udumyan, R., Henriksson, I., Tysk, C., Montgomery, S., & Halfvarson, J. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.07.006 · Cited by 28
Self-citation
A Current State of Proteomics in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Search and Review
Fabián, O., Bajer, L., Drastich, P., Harant, K., Sticová, E., Ďásková, N., Módos, I., Tichánek, F., & Cahová, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119386 · Cited by 27
Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study
Fernández, A., Hernández, V., Martı́nez-Ares, D., Sanromán, L., de Castro, M. L., Pineda, J. R., Carmona, A., González-Portela, C., Salgado, C., Martínez-Cadilla, J., et al. (2015) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2015.03.001 · Cited by 26
Perspectives on an Acceptance and Commitment Therapy (ACT) based program for patients with inflammatory bowel disease and comorbid anxiety and/or depressive symptoms.
Dober, M., Mikocka-Walus, A., Evans, S., Beswick, L., Emerson, C., & Olive, L. (2021) · Psychotherapy Research · doi:10.1080/10503307.2020.1813915 · Cited by 25
“To maximise patient diversity, a literature review and clinical experience identified that age, gender, IBD subtype, and time since diagnosis were likely to influence lived experience (Burisch et al., 2014; Burisch & Munkholm, 2015; Mikocka-Walus et al., 2016a, 2016b).”
Background
Crohn's disease in Korea: past, present, and future
Lee, K., & Lee, J. M. (2014) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2014.29.5.558 · Cited by 25
“Compared with UC, the age at diagnosis for CD is about 10 years earlier in both the West and the East.”
BackgroundResultInfluential
Gut Serpinome: Emerging Evidence in IBD
Mkaouar, H., Mariaule, V., Rhimi, S., Hernandez, J. L., Kriaa, A., Jablaoui, A., Akermi, N., Maguin, E., Lesner, A., Korkmaz, B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116088 · Cited by 23
“Funding: This work received funding from the ANR: Titan-ANR number ANR-18-CE18-0019-03 and SerpinGuTarget ANR-CE16-0018-01 projects, CMCU-PHC Utique (No. 19G0819)-Campus France (41786NC) and Twinning European project MICAfrica 952583.”
BackgroundInfluential
Houttuynia cordata polysaccharides alleviate ulcerative colitis by restoring intestinal homeostasis
Cen, L., Yi, T., Hao, Y., Chenchen, S. H. I., Shi, X., Lu, Y., Chen, D., & Zhu, H. (2022) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(22)60220-6 · Cited by 27
Health care and patients' education in a European inflammatory bowel disease inception cohort: An ECCO-EpiCom study
Burisch, J. M., Végh, Z., Pedersen, N., Cukovic-Cavka, S., Turk, N., Kaimakliotis, I. P., Ďuricová, D., Bortlík, M., Shonová, O., Thorsgaard, N., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.12.023 · Cited by 25
“Ileocolonic ± upper disease 73 (27) 27 (31) Isolated upper disease 23 (8) 1 (1) Missing** 4 (1) 1 (1)”
Self-citation
ANALYSIS OF RISK FACTORS AND POSTOPERATIVE COMPLICATIONS IN PATIENTS WITH CROHN’S DISEASE
Saad-Hossne, R., Sassaki, L. Y., Baima, J. P., Júnior, J. D. D. M., & Campos, L. M. (2018) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.201800000-63 · Cited by 25
“2 per 100,000 people per year, and its prevalence in North America is 26 to 199 cases per 100,000 inhabitants per year(3-5).”
Background
Identification of Three Novel Susceptibility Loci for Inflammatory Bowel Disease in Koreans in an Extended Genome-Wide Association Study
Jung, S., Ye, B. D., Lee, H., Baek, J., Kim, G., Park, D., Park, S. H., Yang, S., Han, B., Liu, J., et al. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab060 · Cited by 23
Regulation of antiapoptotic and cytoprotective pathways in colonic epithelial cells in ulcerative colitis
Seidelin, J. B. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2016.1101245 · Cited by 24
“[2] The highest prevalence rates are found in Western Europe and Northern America; more than 20,000 Danish patients are estimated to suffer from UC, and the incidence of the disease seems to be increasing globally.[3,4] The risk of developing colorectal cancer is increased in patients with early onset of UC, those wit…”
Background
Making sense of the cause of Crohn’s – a new look at an old disease
Segal, A. W. (2016) · F1000Research · doi:10.12688/f1000research.9699.2 · Cited by 25
Fungal dysbiosis predicts the diagnosis of pediatric Crohn’s disease
Mouzan, M. I. E., Korolev, K. S., Mofarreh, M. A. A., Menon, R., Winter, H. S., Sarkhy, A. A. A., Dowd, S. E., Barrag, A. A., & Assiri, A. A. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i39.4510 · Cited by 24
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain
Chaparro, M., Acosta, M. B., Benítez, J. M., Cabriada, J. L., Casanova, M. J., CEBALLOS, D. S., Esteve, M., Fernández, H., Ginard, D., Gomollón, F., et al. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819847034 · Cited by 24
No Change in Surgical and Hospitalization Trends Despite Higher Exposure to Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease in the Québec Provincial Database From 1996 to 2015
Verdon, C., Reinglas, J., Coulombe, J., Gönczi, L., Bessissow, T., Afif, W., Vutcovici, M., Wild, G., Seidman, E. G., Bitton, A., et al. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa166 · Cited by 24
Self-citation
Lived experience in people with inflammatory bowel disease and comorbid anxiety and depression in the United Kingdom and Australia
Mikocka-Walus, A., Hanlon, I., Dober, M., Emerson, C., Beswick, L., Selinger, C., Taylor, J., Olive, L., Evans, S., & Hewitt, C. (2021) · Journal of Health Psychology · doi:10.1177/1359105320911427 · Cited by 23
“The diverse characteristics of the sample were chosen to maximise variation in lived experience and were applied across the following patient participant variables that from the literature and clinical input are likely to influence this: age, sex, IBD duration and severity, having anxiety or depression or both (Burisc…”
Method
Annual Incidence and Phenotypic Presentation of IBD in Southern New Zealand: An 18-Year Epidemiological Analysis
Coppell, K. J., Galts, C., Huizing, F. Y., Norton, J. K., Gray, A. R., Schultz, K., Hobbs, C. E., Aluzaite, K., & Schultz, M. (2018) · Inflammatory Intestinal Diseases · doi:10.1159/000492615 · Cited by 23
High ulcerative colitis and Crohn's disease ratio in a population-based registry from Córdoba, Argentina
Balderramo, D. C., Trakál, J. J., Najum, P. H., Vivas, M., Gonzalez, R., Benavidez, A., Villa, D. L., Daino, D. F., Raiden, K., Germán, A., et al. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.01.006 · Cited by 23
Incidence, Prevalence, Disease Course, and Treatment Strategy of Crohn’s Disease Patients from the Veszprem Cohort, Western Hungary: A Population-based Inception Cohort Study Between 2007 and 2018
Gönczi, L., Lakatos, L., Kürti, Z., Golovics, P. A., Pandúr, T., Dávid, G., Erdélyi, Z., Szita, I., & Lakatos, P. L. (2022) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjac132 · Cited by 22
Self-citation
Incidence of inflammatory bowel disease in Iceland 1995 – 2009. A nationwide population-based study
Björnsson, S., Tryggvason, F. Þ., Jonasson, J. G., Cariglia, N., Örvar, K. B., Kristjánsdóttir, S., & Stefánsson, T. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1047792 · Cited by 22
“Our results are comparable to the results from Iceland in the ECCO Epicom Study [5].”
MethodResult
The Risk of Inflammatory Bowel Disease in Subjects Presenting With Perianal Abscess: Findings From the THIN Database
Thomas, T. R., Chandan, J. S., Harvey, P., Bhala, N. B., Ghosh, S. K., Nirantharakumar, K., & Trudgill, N. J. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy210 · Cited by 21
Positive Predictive Value of Diagnostic Codes for Inflammatory Bowel Disease in the Danish National Patient Registry Among Individuals 50+ Years, Using Patient Records as Reference Standard
Rye, C., Rubin, K. H., Møller, F. T., Julsgaard, M., Jess, T., & Andersen, V. C. (2021) · Clinical Epidemiology · doi:10.2147/clep.s298770 · Cited by 21
“000 for UC.1,2 IBD is a multifactorial disease in which an inflammatory response occurs in genetically disposed individuals when exposed to environmental and microbiological risk factors.”
BackgroundInfluentialSelf-citation
Prevalence and drug treatment practices of inflammatory bowel diseases in Poland in the years 2012–2014: an analysis of nationwide databases
Holko, P., Kawalec, P., & Stawowczyk, E. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001047 · Cited by 21
EPIDEMIOLOGICAL PROFILE AND CLINICAL CHARACTERISTICS OF INFLAMMATORY BOWEL DISEASES IN A BRAZILIAN REFERRAL CENTER
FUCILINI, L. M. P., Genaro, L. M., SOUSA, D. C. E., Cláudio Saddy Rodrigues, C. O. Y., Leal, R. F., & AYRIZONO, M. D. L. S. (2021) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.202100000-87 · Cited by 20
Protective effect of naringin ameliorates TNBS‐induced colitis in rats via improving antioxidant status and pro-inflammatory cytokines
Hambardikar, V. R., & Mandlik, D. S. (2022) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2022.2049813 · Cited by 20
“and increasing the risk of developing colorectal cancer [7,8].”
Background
Crohn’s Disease: Basic Characteristics of the Disease, Diagnostic Methods, the Role of Biomarkers, and Analysis of Metalloproteinases: A Review
Pasternak, G., Chrzanowski, G., Aebisher, D., Myśliwiec, A., Dynarowicz, K., Bartusik‐Aebisher, D., Sosna, B., Cieślar, G., Kawczyk‐Krupka, A., & Filip, R. (2023) · Life · doi:10.3390/life13102062 · Cited by 21
“This leads to them becoming myoﬁ-broblasts [43,44].”
Sarcopenia and frailty in inflammatory bowel disease: Emerging concepts and evidence
Neelam, P. B., Sharma, A., & Sharma, V. (2024) · JGH Open · doi:10.1002/jgh3.13033 · Cited by 23
Inflammatory bowel disease incidence in Czech children: A regional prospective study, 2000-2015
Schwarz, J., Sýkora, J., Cvalínová, D., Pomahačová, R., Klečková, J., Kryl, M., & Včelák, P. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i22.4090 · Cited by 20
Inflammatory bowel disease incidence, prevalence and 12‐month initial disease course in Tasmania, Australia
Bhatia, R., Yeoh, S. W., Vaz, K., Studd, C., Wilson, J., Bell, S., Otáhal, P., & Venn, A. (2018) · Internal Medicine Journal · doi:10.1111/imj.14111 · Cited by 20
Characteristics of Pediatric Crohn’s Disease in Saudi Children: A Multicenter National Study
Saadah, O. I., Mouzan, M. I. E., Mofarreh, M. A. A., Mehaidib, A. A., Edreesi, M. A., Hasosah, M. Y., Al‐Hussaini, A. A., & AlSaleem, K. (2015) · Gastroenterology Research and Practice · doi:10.1155/2016/7403129 · Cited by 20
“Our data also indicated significant delay from the time of appearance of the first symptoms to the time of diagnosis (median delay of 24 months): this was longer than the median time reported in previous studies [33–35].”
Result
Association betweenNOD2/CARD15gene polymorphisms and Crohn's disease in Chinese Zhuang patients
Long, W.-Y. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i16.4737 · Cited by 19
Prevalence and incidence of inflammatory bowel disease in two Italian islands, Sicily and Sardinia: A report based on health information systems
Macaluso, F. S., Mocci, G., Orlando, A., Scondotto, S., Fantaci, G., Antonelli, A., Leone, S., Previtali, E., Cabras, F., & Cottone, M. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.05.017 · Cited by 19
The Incidence and Prevalence of Inflammatory Bowel Disease Continues to Increase in the Faroe Islands – A Cohort Study from 1960 to 2020
Nielsen, K. R., Midjord, J., Lophaven, S., Langholz, E., Hammer, T., & Burisch, J. M. (2023) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjad155 · Cited by 19
Self-citation
Mesenteric lymph nodes: a critical site for the up-regulatory effect of hUC-MSCs on Treg cells by producing TGF-β1 in colitis treatment
Zhang, Q., Zeng, Z., Wei, N., Su, Y., Wang, J., Ni, Q., Wang, Y., Yang, J., Liu, X., Xu, H., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03809-x · Cited by 19
“Inflammatory bowel disease (IBD), mainly including ulcerative colitis (UC) and Crohn’s disease (CD), has emerged as a global disease with no available cure [1, 2], which is characterized by recurrent chronic inflammation of the gastrointestinal tract [3, 4].”
Background
Past, current, and future trends in the prevalence of primary sclerosing cholangitis and inflammatory bowel disease across England (2015–2027): a nationwide, population-based study
Crothers, H., Ferguson, J., Quraishi, M. N., Cooney, R. M., Iqbal, T. H., & Trivedi, P. J. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.101002 · Cited by 23
Incidence, Disease Burden, and Clinical Presentation of Patients Newly Diagnosed With Inflammatory Bowel Disease in a Population-Based Inception Cohort
Attauabi, M., Madsen, G. R., Bendtsen, F., Seidelin, J. B., & Burisch, J. M. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae176 · Cited by 20
Self-citation
Risk factors and timing for colectomy in chronically active refractory ulcerative colitis: A systematic review
Macaluso, F. S., Cavallaro, F., Felice, C., Mazza, M., Armuzzi, A., Gionchetti, P., Vecchi, M. L., & Orlando, A. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.01.018 · Cited by 19
Colectomy Rates for Ulcerative Colitis Differ between Ethnic Groups: Results from a 15-Year Nationwide Cohort Study
Misra, R., Askari, A., Faiz, O. D., & Arebi, N. (2016) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2016/8723949 · Cited by 17
“Cultural changes such as Westernisation of the diet may play an important role in the differences [19].”
Self-citation
Inflammatory bowel disease among Bedouin Arabs in southern Israel
Abu‐Freha, N., Schwartz, D., Elkrinawi, J., Yakov, G. B., Tailakh, M. A., Munteanu, D., Ganim, A. A., & Fich, A. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000263 · Cited by 17
Self-citation
Validation of the ‘United Registries for Clinical Assessment and Research’ [UR-CARE], a European Online Registry for Clinical Care and Research in Inflammatory Bowel Disease
Burisch, J. M., Gisbert, J. P., Siegmund, B., Bettenworth, D., Thomsen, S. B., Cleynen, I., Cremer, A., Ding, N. S., Furfaro, F., Galanopoulos, M., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy015 · Cited by 16
Self-citation
A model of an inflammatory bowel disease population-based registry: The Forlì experience (1993–2013)
Valpiani, D., Manzi, I., Mercuriali, M., Giuliani, O., Ravaioli, A., Colamartini, A., Bucchi, L., Falcini, F., & Ricci, E. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.09.120 · Cited by 16
Development of a self-care questionnaire for clinical assessment of self-care in patients with inflammatory bowel disease: A psychometric evaluation
Wickman, U. L., Yngman‐Uhlin, P., Hjortswang, H., Wenemark, M., Stjernman, H., Riegel, B. J., & Frisman, G. H. (2018) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2018.08.016 · Cited by 16
Diagnostic delay in inflammatory bowel diseases in a German population
Blüthner, E., Dehe, A., Büning, C., Siegmund, B., Prager, M., Maul, J., Krannich, A., Preiß, J., Wiedenmann, B., Rieder, F., et al. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i29.3465 · Cited by 17

Authors: Burisch, J., Pedersen, N., Čuković-Čavka, S., Brinar, M., Kaimakliotis, I., Duricova, D., Shonová, O., Vind, I., Avnstrøm, S., Thorsgaard, N., Andersen, V, Krabbe, S., Dahlerup, J. F., Salupere, R., Nielsen, K. R., Olsen, J., Manninen, P., Collin, P., Tsianos, E. V., Katsanos, K. H., Ladefoged, K., Lakatos, L., Björnsson, E., Ragnarsson, G., Bailey, Y., Odes, S., Schwartz, D., Martinato, M., Lupinacci, G., Milla, M., De Padova, A., D'Incà, R., Beltrami, M., Kupcinskas, L., Kiudelis, G., Turcan, S., Tighineanu, O., Mihu, I., Magro, F., Barros, L. F., Goldis, A., Lazar, D., Belousova, E., Nikulina, I., Hernandez, V, Martinez-Ares, D., Almer, S., Zhulina, Y., Halfvarson, J., Arebi, N., Sebastian, S., Lakatos, P. L., Langholz, E., Munkholm, P., & for the EpiCom-group
Affiliations: Herlev Hospital (DK)
Division of Gastroenterology and Hepatology, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia
University Hospital Centre Zagreb (HR)
Nicosia private practice, Nicosia, Cyprus
IBD Centre ISCARE, Charles University, Prague, Czech Republic
Nemocnice České Budějovice (CZ)
Amager Hospital (DK)
Regionshospitalet Herning (DK)
University of Southern Denmark (DK)
Regionshospitalet Viborg (DK)
Aarhus University Hospital (DK)
Tartu University Hospital (EE)
Medical Department, The National Hospital of the Faroe Islands, Torshavn, Faroe Islands
Tampere University Hospital (FI)
University Hospital of Ioannina (GR)
Queen Ingrid's Hospital (GL)
1st Department of Medicine, Semmelweis University, Budapest, Hungary
Department of Internal Medicine, Section of Gastroenterology and Hepatology, The National University Hospital, Reykjavik, Iceland
National University Hospital of Iceland (IS)
Tallaght University Hospital (IE)
Ben-Gurion University of the Negev (IL)
University of Padua (IT)
Azienda Ospedaliera Ospedale Maggiore (IT)
Azienda Ospedaliero-Universitaria Careggi (IT)
UO Gastroenterologia ed Endoscopia Digestiva, Ospedale Morgagni—Pierantoni, Forlì, Italy
Santa Maria Nuova Hospital (IT)
Institute for Digestive Research, Lithuanian University of Health Sciences, Kaunas, Lithuania
Lithuanian University of Health Sciences (LT)
Moldova State University (MD)
Department of Paediatric Gastroenterology, Centre of Mother and Child, Chisinau, Republic of Moldova
Universidade do Porto (PT)
Hospital de Vale de Sousa, Porto, Portugal
Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
Clinic of Gastroenterology, University of Medicine ‘Victor Babes’, Timisoara, Romania
Department of Gastroenterology, Moscow Regional Research Clinical Institute, Moscow, Russia
Gastroenterology Department, Complexo Hospitalario Universitario de Vigo, Vigo, Spain
Linköping University (SE)
Örebro University Hospital (SE)
Örebro University (SE)
St Mark's Hospital (GB)
Hull Royal Infirmary (GB)
Gentofte Hospital (DK)
Corresponding author: Burisch, J
ORCID: Burisch, J
Pedersen, N
Brinar, M
Andersen, V
Dahlerup, J F
Salupere, R
Nielsen, K R
Collin, P
Schwartz, D
Martinato, M
D'Incà, R
Kiudelis, G
Turcan, S
Magro, F
Almer, S
Halfvarson, J
Arebi, N
Sebastian, S
Langholz, E
Munkholm, P
Venue: Gut
Publisher: BMJ
Published: 2013-04-20
Volume: 63
Issue: 4
Pages: 588-597
ISSN: 0017-5749 (ISSN-L)
1468-3288
DOI: 10.1136/gutjnl-2013-304636
OpenAlex: W2126103084
Cited by: 429
References: 46
Citations by year: 2026: 10 · 2025: 21 · 2024: 26 · 2023: 31 · 2022: 49 · 2021: 33 · 2020: 31 · 2019: 26 · 2018: 39 · 2017: 44 · 2016: 38 · 2015: 33 · 2014: 38 · 2013: 7
FWCI: 25.66
Type: journal article
Language: en
Open access: green
ibn.idsi.md
Licence: other-oa
Locations: Gut (publishedVersion)
PubMed (publishedVersion)
Lithuanian University of Health Sciences (submittedVersion)
HighWire Press Open Archive (submittedVersion)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Scopus (Elsevier) (submittedVersion)
RUNA. Repositorio Institucional del Sergas (Servicio Gallego de Salud (SERGAS)) (submittedVersion, other-oa)
University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
Hirsla (Landspítali University Hospital) (submittedVersion, other-oa)
Topics: Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
Keywords: inflammatory bowel disease, Crohn's disease, ulcerative colitis, IBD-unclassified, incidence, east-west gradient, Eastern Europe, Western Europe, inception cohort, colonoscopy, early surgical intervention, biologic therapy, 5-aminosalicylates, disease severity, risk factors, socioeconomic status, alcohol consumption, gut microbiota
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Colitis, Ulcerative, Colonoscopy, Crohn Disease, Europe, Europe, Eastern, Female, Humans, Male, Middle Aged, Prospective Studies, Inflammatory Bowel Diseases, Incidence, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks